Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Chronic Hepatitis B Clinical Trials

29 recruiting trials for Chronic Hepatitis B. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
29
Total Trials
29
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT02863757

Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease

The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular...

Sponsor: Humanity and Health Research CentreEnrolling: 15001 location
RECRUITINGPhase 4NCT05853718

Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

The purpose of this study is to evaluate the pharmacokinetics, efficacy and safety of TAF in HBV-infected pregnant women.

Sponsor: First People's Hospital of HangzhouEnrolling: 501 location
RECRUITINGNCT06779864

Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance

Patients with a confirmed diagnosis of chronic hepatitis B (CHB) who have complete clinical data and retained blood or liver tissue samples will be enrolled. All patients will be...

Sponsor: Beijing Friendship HospitalEnrolling: 20001 location
RECRUITINGNCT06803368

Research on Clinical Recovery and Maintenance Strategies for CHB

Collect basic information of patients before antiviral treatment and when HBsAg disappears, and divide them into three groups A, B, and C based on baseline anti HBs titers after...

Sponsor: Beijing Municipal Administration of HospitalsEnrolling: 2851 location
RECRUITINGPhase 2NCT06154278

Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B

The goal of this clinical trial is to learn about the action of Imdusiran (AB-729) in the liver of people with chronic hepatitis B. The main questions it aims to answer are: *...

Sponsor: University of Maryland, BaltimoreEnrolling: 101 location
RECRUITINGNCT06779058

MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B

How to construct a non-invasive, accurate, and convenient method to evaluate the severity of liver fibrosis (LF) is an important general problem in the management of patients with...

Sponsor: Shengjing HospitalEnrolling: 6001 location
RECRUITINGNCT05671315

A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients

China's new cases and deaths of hepatocellular carcinoma (HCC) rank first in the world. hepatocellular carcinoma is the third most morbid, second-most mortal malignancy in China....

Sponsor: Qing XIeEnrolling: 2679 locations
RECRUITINGPhase 1NCT05727267

A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate

This study is an open-label, ascending dose phase 1a trial to assess the safety and immunogenicity of a heterologous protein prime/MVA boost therapeutic hepatitis B vaccine

Sponsor: Universitätsklinikum Hamburg-EppendorfEnrolling: 242 locations
RECRUITINGPhase 1 / Phase 2NCT06295328

From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients

Rationale: Currently, there is no curative therapy available for patients that are chronically infected with the hepatitis B virus (HBV). Especially the presence of a viral...

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Enrolling: 361 location
RECRUITINGPhase 4NCT03792919

Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)

To Identify the collected cases who can stop NAs safely with satisfactory clinical outcome including sustain viral remission and HBsAg clearance among chronic hepatitis B(CHB)...

Sponsor: Humanity & Health Medical Group LimitedEnrolling: 20001 location
RECRUITINGPhase 2NCT05769816

A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained...

Hepatitis B virus (HBV) infection is a major public health threat in China. At present, a functional cure, also known as clinical cure or sustained Hepatitis B surface antigen...

Sponsor: The Second Affiliated Hospital of Chongqing Medical UniversityEnrolling: 1201 location
RECRUITINGPhase 1NCT06671093

Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

This study will be conducted to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of Tune-401 in adult participants with Chronic Hepatitis B.

Sponsor: Tune Therapeutics, Inc.Enrolling: 363 locations
RECRUITINGPhase 2NCT06092333

VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

Background: Chronic hepatitis B virus (HBV) infection affects 292 million people worldwide; 887,000 die each year from cirrhosis, liver cancer, and related issues. Treatment...

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling: 501 location
RECRUITINGPhase 2NCT06993480

A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic...

AB-10-8005 is a single-center, open-label Phase II clinical study to evaluate the antiviral activity and immune responses of AHB-137 injection in participants with CHB treated...

Sponsor: Ausper Biopharma Co., Ltd.Enrolling: 301 location
RECRUITINGPhase 2NCT05771402

A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained...

Hepatitis B virus (HBV) infection is a major public health threat in China. At present, a functional cure, also known as clinical cure or sustained Hepatitis B surface antigen...

Sponsor: The Second Affiliated Hospital of Chongqing Medical UniversityEnrolling: 1201 location
RECRUITINGPhase 1NCT07275918

SA1211 Injection Phase 1 Study

The goal of this clinical trial is to evaluate the safety, tolerability, immunogenicity and Pharmacokinetics (PK) characteristics of SA1211 Injection in healthy volunteers (Part...

Sponsor: Suzhou Siran Biotechnology Co.,Ltd.Enrolling: 801 location
RECRUITINGPhase 1NCT06885710

HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients

This is a open-label study to evaluate the safety and efficacy of autologous T-cells transfected with messenger ribonucleic acid (mRNA) encoding Hepatitis-B virus (HBV) antigen...

Sponsor: Changhai HospitalEnrolling: 191 location
RECRUITINGNCT07169656

Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.

This study is a multicenter, prospective, observational real-world study designed to investigate and analyze the current treatment patterns of chronic hepatitis B (CHB) across 200...

Sponsor: The First Affiliated Hospital of Zhengzhou UniversityEnrolling: 1500020 locations
RECRUITINGNCT02883647

Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b

The study is to observe the therapeutic effects and long-term follow-up after ending anti-HBV therapy with nucleos(t)ide analogs in patients with chronic hepatitis b.

Sponsor: Third Affiliated Hospital, Sun Yat-Sen UniversityEnrolling: 1001 location
RECRUITINGPhase 2NCT06566248

A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside...

To evaluate the efficacy and safety of combined/uncombined nucleoside (acid) analogues of TQA3810 tablets.

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Enrolling: 906 locations
RECRUITINGPhase 1NCT04843852

TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B

The goal of this clinical trial is to learn if HEPLISAV-B, a vaccine that is approved to prevent hepatitis B infection in people that are not already infected, is safe in people...

Sponsor: University of Maryland, BaltimoreEnrolling: 101 location
RECRUITINGPhase 4NCT06368882

Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic...

This is a prospective, multicenter, open-label, non-randomized controlled real-world study to explore the efficacy and safety and to accumulate more evidence-based medical data of...

Sponsor: First Affiliated Hospital of Wenzhou Medical UniversityEnrolling: 15005 locations
RECRUITINGPhase 2NCT06263959

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of...

A randomized, double-blind, placebo-controlled Phase IIa clinical study to evaluate the safety and efficacy of GST-HG131 tablets in patients with chronic hepatitis B

Sponsor: Fujian Akeylink Biotechnology Co., Ltd.Enrolling: 451 location
RECRUITINGPhase 2NCT02932150

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

The goals of this clinical study are to compare the effectiveness, safety and tolerability of study drug, tenofovir alafenamide (TAF), versus placebo in teens and children with...

Sponsor: Gilead SciencesEnrolling: 15020 locations
RECRUITINGPhase 2NCT06425341

A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection...

A multicenter, randomized, open, parallel-designed Phase II study to evaluate the efficacy and safety of HRS-5635 injection alone or in combination with other agents in patients...

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.Enrolling: 3691 location
RECRUITINGNCT04139850

The Establishment of Korean Hepatitis B Patients Cohort

According to the World Health Organization about 1,400,000 deaths reported annually, are related to chronic liver disease. Chronic liver disease is very prevalent in South Korea,...

Sponsor: Yonsei UniversityEnrolling: 20001 location
RECRUITINGNCT07257562

Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance

The goal of this prospective observational study is to determine the effects of concomitant administration of Bacteroides fragilis and Branched-Chain Amino Acids on hepatitis B...

Sponsor: First Affiliated Hospital of Fujian Medical UniversityEnrolling: 401 location
RECRUITINGNCT06047093

Fine Needle Aspiration (FNA) Evaluation of the Intrahepatic HBV Reservoir and Its Immunological Characteristics in...

Two hundred and ninety-six million people worldwide are chronically infected with the hepatitis B virus (HBV), with around 750,000 deaths each year linked to the development of...

Sponsor: Hospices Civils de LyonEnrolling: 1001 location
RECRUITINGNCT06323681

Pegylated Interferon α in Previously Interferon-treated CHB(Leading Study)

Previous clinical practice and exploratory studies suggest that some patients who have not achieved functional cure in the first round of interferon therapy can achieve HBsAg...

Sponsor: Qing XIeEnrolling: 20161 location